The Carlat Psychiatry Podcast

Managing Metabolic Side Effects in Schizophrenia

12.08.2021 - By Pocket Psychiatry: A Carlat PodcastPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Individuals with schizophrenia are at high risk of obesity, elevated lipids, increased insulin resistance, diabetes, and cardiovascular disease. On average, people with schizophrenia die 20–25 years sooner than those without schizophrenia. How can we spot metabolic side effects early in our patients, and what should we be looking for exactly? CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test here (https://www.thecarlatreport.com/carlat-psychiatry-podcast-cme-subscription/).Published On: 12/8/2021Duration: 16 minutes, 42 secondsReferenced Article: “Weight Gain and Metabolic Side Effects (https://www.thecarlatreport.com/the-carlat-hospital-psychiatry-report/weight-gain-and-metabolic-side-effects/),” The Carlat Hospital Psychiatry Report, July/August/September 2021Victoria Hendrick, MD, and Stephen Marder, MD, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

More episodes from The Carlat Psychiatry Podcast